US100 fully reverses Asian session losses, sits just 0.3% from historical peak
The US100 is up 0.4% today, approaching the 25,000 mark and sitting just 0.3% shy of its all-time high. The contract has fully reversed the decline that began yesterday evening and lasted until the start of the European session. Furthermore, gains on the Nasdaq 100 futures accelerated sharply upon the opening of Wall Street today.
The rally is occurring despite the ongoing government shutdown. While the shutdown may have limited immediate impact on the operations of key technology companies, Wall Street indices have historically tended to gain during government closures—an outcome that often appears counter-intuitive. Nevertheless, the shutdown increases the likelihood of a deterioration in the labour market, which could compel the Federal Reserve to cut interest rates.
Start investing today or test a free demo
Create account Try a demo Download mobile app Download mobile appToday's ADP report showed a loss of 32,000 private-sector jobs. This is the worst reading for private employment since January 2021. Furthermore, previous data was revised downwards.
The main drivers today are biotechnology and pharmaceutical stocks, even though the government shutdown may cause a slowdown in areas like new drug approvals. Chip manufacturers form the second strongest cohort of gaining stocks today.
Stocks within the Nasdaq 100 are split almost fifty-fifty in terms of gains and losses today. Source: Bloomberg Finance LP
The US100 has rebounded by approximately 1% (around 300 points) from its session low today. Source: xStation5The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
